NCT06506890

Brief Summary

This is a CONTROLLED PROSPECTIVE COHORT study of a long-term care facility. At the start of the study a dedicated section A of the facility ventilation system will have routine HVAC filters of the same dimensions installed, while section B of the same facility ventilation system will have C-POLAR (cationic polymeric coated) HVAC filters installed. There will be continuous Indoor Air Quality monitors (PM 2.5, CO2, VOC, Radon, Temp, and RH) installed at different vent locations throughout the long-term care facility for the duration of the study. Air samples with an Airport MD8 BAMS machine will be taken once a week at various vent locations at the long-term care facility.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 18, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 5, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

July 22, 2024

Status Verified

July 1, 2024

Enrollment Period

10 months

First QC Date

July 11, 2024

Last Update Submit

July 18, 2024

Conditions

Keywords

Long-term careAir QualityHVAC Filter

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint is comparing the difference in reduction of bioaerosols between MERV 13 HVAC filters.

    The aim of this study is to determine the difference in reduction of bioaerosols in a long-term care facility with MERV 13 C-POLAR (cationic polymeric coated) HVAC filters compared to conventional MERV 13 HVAC filters.

    Nine Months

Study Arms (1)

comparing the difference in reduction of bioaerosols between HVAC filters

OTHER

comparing the difference in reduction of bioaerosols between HVAC filters.

Other: Use of C-Polar coated HVAC Filter versus conventional HVAC Filter

Interventions

comparing the difference in reduction of bioaerosols between HVAC filters.

Also known as: comparing the difference in reduction of bioaerosols between HVAC filters.
comparing the difference in reduction of bioaerosols between HVAC filters

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \. Any resident, staff, and any individual who enters the long term care facility will be in a broad sense, involved in this study, as the MERV 13 HVAC filters will be installed within the HVAC system and will not allow anyone to not participate in the study who enters the facility. It is impracticable to carry out this research of comparing two different HVAC filters in an active long term care setting by receiving prior consent from all individuals who may enter, such as vendors or visitors. This research involves no more than minimal risk and may or may not improve air quality or minimize bioaerosols in the facility.

You may not qualify if:

  • \. Does not wish to enter the long-term care facility until completion of study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kelowna General Hospital

Kelowna, British Columbia, V1Y 1T2, Canada

Location

Study Officials

  • Deanne Taylor, PhD

    Kelowna General Hospital

    PRINCIPAL INVESTIGATOR
  • Michael Mansour, MD, PhD

    Harvard Medical School (HMS and HSDM)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 11, 2024

First Posted

July 18, 2024

Study Start

September 5, 2024

Primary Completion

June 30, 2025

Study Completion

August 31, 2025

Last Updated

July 22, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

All participant data will be anonymized

Locations